{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T20:08:01Z","timestamp":1779394081415,"version":"3.53.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1097\/ftd.0000000000000283","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T13:55:25Z","timestamp":1454421325000},"page":"402-406","source":"Crossref","is-referenced-by-count":10,"title":["Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates"],"prefix":"10.1097","volume":"38","author":[{"given":"Erik M.","family":"van Maarseveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwen","family":"Sprij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210129","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00003495-199958030-00003","article-title":"Antibiotics in neonatal infections: a review","volume":"58","author":"Fanos","year":"1999","journal-title":"Drugs"},{"key":"R2-20-20210129","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"R3-20-20210129","doi-asserted-by":"crossref","first-page":"F4","DOI":"10.1136\/adc.2009.178483","article-title":"Empirical treatment of neonatal sepsis: are the current guidelines adequate?","volume":"96","author":"Muller-Pebody","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R4-20-20210129","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/jac\/dku175","article-title":"Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients","volume":"69","author":"van Maarseveen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R5-20-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003088-200948020-00001","article-title":"Therapeutic drug monitoring of aminoglycosides in neonates","volume":"48","author":"Touw","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"R6-20-20210129","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/jac\/dkv052","article-title":"Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates","volume":"70","author":"Valitalo","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R7-20-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/clinchem\/43.1.222","article-title":"Therapeutic drug monitoring principles in the neonate","volume":"43","author":"Koren","year":"1997","journal-title":"Clin Chem"},{"key":"R8-20-20210129","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","article-title":"Experience with a once-daily aminoglycoside program administered to 2,184 adult patients","volume":"39","author":"Nicolau","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/520991","article-title":"Back to the future: using aminoglycosides again and how to dose them optimally","volume":"45","author":"Drusano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R10-20-20210129","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2165\/11597020-000000000-00000","article-title":"Pharmacological considerations for the proper clinical use of aminoglycosides","volume":"71","author":"Pagkalis","year":"2011","journal-title":"Drugs"},{"key":"R12-20-20210129","first-page":"98","article-title":"An extended-interval gentamicin dosing regimen in newborns","volume":"13","author":"Sum","year":"2007","journal-title":"Eur J Hosp Pharm Sci"},{"key":"R14-20-20210129","first-page":"587","article-title":"American academy of pediatrics committee on fetus and newborn, levels of neonatal care.","volume":"130","year":"2012","journal-title":"Pediatrics"},{"key":"R15-20-20210129","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-199121060-00006","article-title":"Individualising gentamicin dosage regimens: a comparative review of selected models, data fitting methods and monitoring strategies","volume":"21","author":"Jelliffe","year":"1991","journal-title":"Clin Pharmacokinet"},{"key":"R16-20-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/49.1.13","article-title":"Newborns and gentamicin\u2013how much and how often?","volume":"49","author":"Chattopadhyay","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"R17-20-20210129","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1542\/peds.103.3.594","article-title":"Once- versus twice-daily gentamicin dosing in neonates >\/=34 Weeks' gestation: cost-effectiveness analyses","volume":"103","author":"Thureen","year":"1999","journal-title":"Pediatrics"},{"key":"R18-20-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00007691-200208000-00011","article-title":"Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates","volume":"24","author":"Stolk","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R19-20-20210129","doi-asserted-by":"crossref","first-page":"F294","DOI":"10.1136\/adc.2004.056317","article-title":"Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis","volume":"90","author":"Nestaas","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R21-20-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000244391","article-title":"Risk factors of sensorineural hearing loss in preterm infants","volume":"71","author":"Borradori","year":"1997","journal-title":"Biol Neonate"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:30:15Z","timestamp":1620952215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201606000-00020"}},"subtitle":["A Prospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000283","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}